NCT02876419View on ClinicalTrials.gov

A Long Term Follow-up Study of Patients From the REP 301 Protocol

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

November 13, 2019

Study Completion Date

December 31, 2019

Conditions
Hepatitis B, ChronicHepatitis D, Chronic
Trial Locations (1)

2004

Infectious Clinical Hospital (n.a. Toma Ciorba), Chisinau

All Listed Sponsors
lead

Replicor Inc.

INDUSTRY

NCT02876419 - A Long Term Follow-up Study of Patients From the REP 301 Protocol | Biotech Hunter | Biotech Hunter